Skip to content
drillr.ai
Sign up

INAB

IN8bio, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.20
+3.45%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue500.0K2.5M—2.5M—
Gross Profit(500.0K)(2.5M)—(2.5M)—
Operating Expenses
R&D Expense9.9M10.2M17.0M16.8M14.1M
SG&A Expense9.3M9.7M12.6M13.5M14.5M
General & Admin Expense9.3M9.7M12.6M13.5M14.5M
Selling & Marketing Expense—————
Other Expenses(858.0K)(2.5M)838.0K(2.5M)—
Total Operating Expenses18.3M17.4M30.4M27.8M28.5M
Cost and Expenses18.8M19.9M30.4M30.3M28.5M
Operating Income (EBIT)(18.8M)(19.9M)(30.4M)(30.3M)(28.5M)
Non-Operating
Interest Income534.0K421.0K230.0K——
Interest Expense—————
Net Interest Income534.0K421.0K230.0K——
Other Non-Op Income/Expense176.0K421.0K—330.0K—
Non-Operating Income (excl Interest)(85.0K)(421.0K)(838.0K)(330.0K)—
EBT (Pre-Tax Income)(18.7M)(19.4M)(30.4M)(30.0M)(28.5M)
Income Tax Expense—————
Bottom Line
Net Income(18.7M)(19.4M)(30.4M)(30.0M)(28.5M)
Earnings from Cont. Ops(18.7M)(19.4M)(30.4M)(30.0M)(28.5M)
Earnings from Discont. Ops—————
Bottom Line Net Income(18.7M)(19.4M)(30.4M)(30.0M)(28.5M)
Per Share
Basic EPS($1.87)($4.44)($17.05)($30.14)($40.81)
Diluted EPS($1.87)($4.44)($17.05)($30.14)($40.81)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding19.5M4.4M1.8M995497698931
Diluted Shares Outstanding19.5M4.4M1.8M995497698931
Profitability Metrics
EBITDA(16.7M)(16.9M)(26.9M)(27.5M)(27.4M)
D&A2.0M2.5M2.7M2.5M1.1M
EBIT(18.8M)(19.4M)(29.6M)(30.0M)(28.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026